November 1, 2016
The study titled “Pharmacokinetic Response after Subcutaneous Administration of Ceftriaxone” was presented on Saturday October 29th. The primary end-point for the study was non-inferior antimicrobial coverage when compared to the same dose given by intravenous infusion. Antimicrobial coverage refers to time over the Minimum Inhibitory Concentration (MIC), a generally accepted measure of the adequacy of...
Complete bioavailability after subcutaneous administration of ceftriaxone — Equivalent antimicrobial coverage (time over MIC) to standard intravenous administration FOR IMMEDIATE RELEASE: Lexington, MA., October 31, 2016 /PRNewswire/ — scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today the presentation of study results at IDWeek 2016 in New Orleans, Louisiana. The...
Once again this year, Lundbeckfonden is awarding talent prizes to four talented young scientists under the age of 30. All four have made remarkable and promising contributions to research at a very early stage of their careers. “Supporting and contributing to the development of the careers of scientists is one of Lundbeckfonden’s cornerstones. These young...


Experienced neuroscientist at the helm of The Brain Prize
30. June 2020
Eight promising young researchers receive Lundbeck Foundation Fellowships
16. June 2020
Denmark Gets Its First Master’s Degree Programme in Neuroscience
4. June 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge